186 related articles for article (PubMed ID: 11264388)
1. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51.
Thimme R; Chang KM; Pemberton J; Sette A; Chisari FV
J Virol; 2001 Apr; 75(8):3984-7. PubMed ID: 11264388
[TBL] [Abstract][Full Text] [Related]
2. Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor.
Bertoletti A; Southwood S; Chesnut R; Sette A; Falco M; Ferrara GB; Penna A; Boni C; Fiaccadori F; Ferrari C
Hepatology; 1997 Oct; 26(4):1027-34. PubMed ID: 9328331
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
[TBL] [Abstract][Full Text] [Related]
4. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
5. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
[TBL] [Abstract][Full Text] [Related]
6. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
Liu Q; Zheng Y; Yu Y; Tan Q; Huang X
Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777
[TBL] [Abstract][Full Text] [Related]
7. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A
Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757
[TBL] [Abstract][Full Text] [Related]
8. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen.
Bertoletti A; Ferrari C; Fiaccadori F; Penna A; Margolskee R; Schlicht HJ; Fowler P; Guilhot S; Chisari FV
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10445-9. PubMed ID: 1660137
[TBL] [Abstract][Full Text] [Related]
9. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
[TBL] [Abstract][Full Text] [Related]
10. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
[TBL] [Abstract][Full Text] [Related]
11. In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus.
Malmassari S; Lone YC; Zhang M; Transy C; Michel ML
Microbes Infect; 2005 Apr; 7(4):626-34. PubMed ID: 15820153
[TBL] [Abstract][Full Text] [Related]
12. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.
Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Virol; 2002 Jan; 76(2):582-90. PubMed ID: 11752149
[TBL] [Abstract][Full Text] [Related]
13. Endogenous expression and HLA stabilization assay of Plasmodium falciparum CTL epitope minigene in human HLA-A2. 1 and HLA-B51 cells.
Tang Y; Wang H
Chin Med Sci J; 2001 Mar; 16(1):29-34. PubMed ID: 12899345
[TBL] [Abstract][Full Text] [Related]
14. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ
Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.
Penna A; Chisari FV; Bertoletti A; Missale G; Fowler P; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1991 Dec; 174(6):1565-70. PubMed ID: 1720813
[TBL] [Abstract][Full Text] [Related]
16. Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules.
Livingston BD; Crimi C; Fikes J; Chesnut RW; Sidney J; Sette A
Hum Immunol; 1999 Nov; 60(11):1013-7. PubMed ID: 10599997
[TBL] [Abstract][Full Text] [Related]
17. Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
Hundemer M; Schmidt S; Condomines M; Lupu A; Hose D; Moos M; Cremer F; Kleist C; Terness P; Belle S; Ho AD; Goldschmidt H; Klein B; Christensen O
Exp Hematol; 2006 Apr; 34(4):486-96. PubMed ID: 16569595
[TBL] [Abstract][Full Text] [Related]
18. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN
J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice.
Zhang Y; Li S; Shan M; Pan X; Zhuang K; He L; Gould K; Tien P
Immunology; 2007 May; 121(1):105-12. PubMed ID: 17244158
[TBL] [Abstract][Full Text] [Related]
20. Human class I supertypes and CTL repertoires extend to chimpanzees.
Bertoni R; Sette A; Sidney J; Guidotti LG; Shapiro M; Purcell R; Chisari FV
J Immunol; 1998 Oct; 161(8):4447-55. PubMed ID: 9780224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
